|
|
|
Volumn 43, Issue 1120, 2001, Pages 109-111
|
|
Darbepoetin (ARANESP) - A long-acting erythropoietin
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
LONG ACTING DRUG;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PAMIDRONIC ACID;
RECOMBINANT ERYTHROPOIETIN;
UNCLASSIFIED DRUG;
ZOLEDRONIC ACID;
ANEMIA;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
DIALYSIS;
DOSE RESPONSE;
DRUG ACCUMULATION;
DRUG APPROVAL;
DRUG COST;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG INFORMATION;
DRUG MARKETING;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
HEMOGLOBIN DETERMINATION;
HUMAN;
HYPERCALCEMIA;
HYPERTENSION ENCEPHALOPATHY;
SEIZURE;
SHORT SURVEY;
URTICARIA;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ERYTHROPOIESIS;
ERYTHROPOIETIN;
FEES, PHARMACEUTICAL;
HUMANS;
KIDNEY FAILURE, CHRONIC;
|
|
EID: 0035842369
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (8)
|
|
References (0)
|